[
  {
    "ts": "2025-06-04T03:32:46+00:00",
    "headline": "Drug Development Inputs & Services Stocks Q1 In Review: Repligen (NASDAQ:RGEN) Vs Peers",
    "summary": "Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Repligen (NASDAQ:RGEN) and the best and worst performers in the drug development inputs & services industry.",
    "url": "https://finance.yahoo.com/news/drug-development-inputs-services-stocks-033246220.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "6259d7ac-b991-3a1d-a80e-442b134dd226",
      "content": {
        "id": "6259d7ac-b991-3a1d-a80e-442b134dd226",
        "contentType": "STORY",
        "title": "Drug Development Inputs & Services Stocks Q1 In Review: Repligen (NASDAQ:RGEN) Vs Peers",
        "description": "",
        "summary": "Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Repligen (NASDAQ:RGEN) and the best and worst performers in the drug development inputs & services industry.",
        "pubDate": "2025-06-04T03:32:46Z",
        "displayTime": "2025-06-04T03:32:46Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/8f84bedd0946cb1f9bace3ad88085eb0",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "RGEN Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZGk2r4CasRDJ8G5hC0XmGA--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/8f84bedd0946cb1f9bace3ad88085eb0.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jsgw9CNEC7uCcJmqDa7pYA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/8f84bedd0946cb1f9bace3ad88085eb0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/drug-development-inputs-services-stocks-033246220.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/drug-development-inputs-services-stocks-033246220.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RGEN"
            },
            {
              "symbol": "UFPT"
            },
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]